Antimyoclonic effect of levetiracetam

Epileptic Disorders

Volumn 2, Issue 4, 2000, Pages 209-212

  Genton, P ^a   Gelisse P ^a  

^a CENTRE SAINT PAUL   (France)

Author keywords

Antiepileptic drugs; Lance Adams syndrome; Levetiracetam; Myoclonus; Post anoxic myoclonus; Unverricht Lundborg disease

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADULT; ANTICONVULSANT ACTIVITY; ARTICLE; CASE REPORT; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MALE; MYOCLONUS; MYOCLONUS EPILEPSY; PRIORITY JOURNAL; TREATMENT OUTCOME; VIDEORECORDING;

ADULT; ANTICONVULSANTS; EPILEPSIES, MYOCLONIC; FEMALE; HUMANS; MALE; MIDDLE AGED; PIRACETAM; SEVERITY OF ILLNESS INDEX;

EID: 0034489874     PISSN: 12949361     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Piracetam in the treatment of different types of myoclonus
2. Effectiveness of piracetam in cortical myoclonus
3. Piracetam in the treatment of cortical myoclonus
4. Piracetam and levetiracetam: Close structural similarities but different pharmacological and clinical profiles
5. Efficacy and tolerability study of ucbL059 in patients with refractory epilepsy
6. A multicentre, double-blind, randomized, parallel-group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2,000 mg daily and 4,000 mg daily, without titration in patients with refractory seizures
7. Profile of UCB LO59, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats
8. Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy
9. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy
10. Photosensitive epilepsy: A model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam
11. Classification of progressive myoclonus epilepsies and related diseases
12. A PCR amplification method reveals instability of the dodecamer repeat in progressive myoclonus epilepsy (EPM1) and no correlation between the size of the repeat and age at onset
13. Treatment of epilepsies with myoclonias
14. Piracetam in the treatment of myoclonus: An overview
15. Antimyoclonic effects of alcohol in progressive myoclonus epilepsy
16. The novel antiepileptic drug levetiracetam (UCB LO59) appears to act via a specific binding site in CNS membranes
17. Functional independence in post-anoxic myoclonus: Contribution of L-5-HTP sodium valproate and clonazepam
18. Effet thérapeutique du piracetam dans un case de myoclonie d'action postanoxique
19. Successful treatment of post-hypoxic action myoclonus with carbamazepine
20. Post-anoxic action myoclonus (Lance-Adams syndrome) treated with levodopa and GABAergic drugs
21. The ramsay hunt syndrome revisited: Mediterranean myoclonus versus mitochondrial encephalomyopathy with ragged red fibers and Baltic myoclonus
22. Piracetam relieves symptoms in progressive myoclonus epilepsy: A multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo